Cholera clinical trials
The registry lists 83 studies for Cholera across more than 10 countries. 16 are recruiting or about to start. 73 of them are mainly about Cholera (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Cholera studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
International Vaccine Institute (19) · International Centre for Diarrhoeal Disease Research, Bangladesh (17) · Johns Hopkins Bloomberg School of Public Health (8) · Bavarian Nordic (5) · PATH (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · University of Maryland, Baltimore (3) · Epicentre (3)
What is being tested here
Drugs under test in Cholera studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 9, phase 3 first
- Dec 2026Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus · Phase 3 · International Vaccine Institute
- Nov 2026Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers · Centre for Infectious Disease Research in Zambia
- Dec 2026Preventative Intervention for Cholera for 7 Days · Johns Hopkins Bloomberg School of Public Health
- Dec 2026Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7) · Johns Hopkins Bloomberg School of Public Health
- Dec 2026Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance · Epicentre
- Mar 2027Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children · International Vaccine Institute
- Jul 2027Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants · International Vaccine Institute
- Aug 2027Ondansetron to Prevent Oral Rehydration Failure in Children With Cholera · Public Interest Science Center
- Nov 2027Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI) · Johns Hopkins Bloomberg School of Public Health
Who these studies take
Of the 13 Cholera studies recruiting now, 7 (54%) set no upper age limit and 5 (38%) stop at 75 or younger. 10 (77%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 9 (69%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 9 (69%) | 9 (69%) |
| 18 | 12 (92%) | 12 (92%) |
| 30 | 12 (92%) | 12 (92%) |
| 40 | 12 (92%) | 12 (92%) |
| 50 | 10 (77%) | 10 (77%) |
| 65 | 8 (62%) | 8 (62%) |
| 75 | 8 (62%) | 8 (62%) |
| 85 | 7 (54%) | 7 (54%) |
Across all 83 studies, recruiting or not: 64% stop at 75 or younger and 64% at 65; 67% take children; 1% are for women only and 6% for men only; 75% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 83. Browse all 83 → or search them.
- Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)RecruitingNCT06003816Not applicable1 country
- Ondansetron to Prevent Oral Rehydration Failure in Children With CholeraNot yet recruitingNCT07795060Phase 21 country
- Phase 1b Ascending Dose Study of PanChol in Healthy VolunteersRecruitingNCT07107516Phase 11 country
- CVD 38000: Study of Responses to Vaccination With Typhoid and/or CholeraRecruitingNCT03705585Phase 41 country
- Cholera Control by Case-area Targeted Interventions (CATIs)RecruitingNCT07685574Not applicable1 country
- Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)RecruitingNCT06498817Not applicable1 country
- Vaccine- and Infection-derived Correlates of Protection for CholeraRecruitingNCT06455852Not applicable1 country
- Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and ChildrenRecruitingNCT07509047Phase 21 country
- Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy ParticipantsNot yet recruitingNCT07270796Phase 11 country
- Extended Dosing Intervals Trial for Oral Cholera Vaccine, KenyaRecruitingNCT07487077Phase 41 country
- Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-PlusRecruitingNCT07304284Phase 31 country
- Preventative Intervention for Cholera for 7 DaysRecruitingNCT05166850Not applicable1 country
- Management of Shock in Children With SAM or Severe Underweight and DiarrheaRecruitingNCT04750070Phase 31 country
- Impact Study of Cholera Vaccination in Endemic Areas - Clinical SurveillanceRecruitingNCT048531861 country
- Co-administration Study of OCV, TCV and MRNot yet recruitingNCT05771779Phase 3
- First in Human Phase 1 Ascending Dose Study of PanChol in Healthy VolunteersRecruitingNCT05657782Phase 11 country
- Single Dose Azithromycin to Prevent Cholera in ChildrenCompletedNCT04326478Phase 21 country
- Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in CholeraCompletedNCT06193408Phase 21 country
- Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery DiarrheaCompletedNCT05814042Phase 2/31 country
- Immunologic Responses to a Live Attenuated Oral Cholera VaccineCompletedNCT03251495Phase 21 country
- Simulation Based Training In Medical StudentsCompletedNCT06929312Not applicable1 country
- Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy AdultsCompletedNCT05559983Phase 11 country
- Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) VaccinesCompletedNCT06104345Phase 41 country
- Impact Study of Cholera Vaccination in Endemic Areas - SeroprevalenceCompletedNCT058297721 country
- Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior ChangeCompletedNCT04816552Not applicable1 country
- Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje MalawiTerminatedNCT02499172Not applicable1 country
- VAXCHORA Pediatric Study to Assess Safety and ImmunogenicityCompletedNCT03220737Phase 41 country
- Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent CholeraCompletedNCT01895855Phase 31 country
- A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy AdultsCompletedNCT02094586Phase 32 countries
- A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older AdultsCompletedNCT02100631Phase 31 country
- Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200CompletedNCT01585181Phase 11 country
- Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™CompletedNCT04760236Phase 31 country
- Immune Response to a Delayed Second Dose of Oral Cholera VaccineStatus unknownNCT05453253Phase 41 country
- To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)Status unknownNCT05732766Phase 31 country
- Blood Donor CVD 9000TerminatedNCT03724357Phase 41 country
- Extended Dose Intervals With Oral Cholera Vaccine in CameroonCompletedNCT03719066Phase 21 country
- Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of CongoCompletedNCT02928341Not applicable1 country
- A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).Status unknownNCT05507229Phase 31 country
- Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical TrialCompletedNCT00142272Phase 31 country
- Cholera-Hospital-Based-Intervention-for-7-daysCompletedNCT04008134Not applicable
- Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult SubjectsCompletedNCT00654108Phase 11 country
- Effect of Extended Dose Intervals on the Immune Response to Oral Cholera VaccineCompletedNCT03373669Phase 41 country
- Cholera Anti-Secretory Treatment TrialCompletedNCT04150250Phase 21 country
- Immunogenicity of Cholera Vaccine in Children With IBDCompletedNCT03998449Not applicable1 country
- Cholera Vaccine Investment Strategy in BangladeshCompletedNCT027278551 country
- PXVX0200 (CVD103-HgR) vs Shanchol in MaliCompletedNCT02145377Phase 21 country
- Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control EffortsCompletedNCT028644331 country
- Immunity to Human Cholera in BangladeshCompletedNCT004019341 country
- Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera VaccineCompletedNCT02823899Phase 1/21 country
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican RepublicCompletedNCT02434822Phase 31 country